Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 7,171,399 shares of BBIO stock, worth $315 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,171,399
Previous 4,907,533
46.13%
Holding current value
$315 Million
Previous $135 Million
84.1%
% of portfolio
0.14%
Previous 0.07%
Shares
24 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$970 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$847 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$655 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$548 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$267 Million73.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.52B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...